Technology Center Malta: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Center Malta.

Press releases published on October 5, 2026

2 hours ago

OnCusp Therapeutics Announces Positive Phase 1b Data Evaluating its CDH6-Directed Antibody-Drug Conjugate, CUSP06, in Platinum-Resistant Ovarian Cancer (PROC) Presented at Plenary Oral Session of the IGCS 2026 Annual Global Meeting

Indeterminate GlobeNewswire

2 hours ago

Forward Therapeutics Announces Positive Phase 1 Data for Potential Best-in-Class Oral TNFR1 Signaling Inhibitor FT2109, Supporting Advancement into Phase 2 Development

Indeterminate GlobeNewswire

2 hours ago

Magnite to Announce Third Quarter 2026 Financial Results on November 4, 2026

Indeterminate GlobeNewswire

2 hours ago

TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement

Indeterminate GlobeNewswire

2 hours ago

Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease

Indeterminate GlobeNewswire

2 hours ago

Sofwave to Participate in the Jefferies Private MedTech Virtual Summit

Indeterminate GlobeNewswire

2 hours ago

Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)

Indeterminate GlobeNewswire

2 hours ago

vTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)

Indeterminate GlobeNewswire

2 hours ago

Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom

Indeterminate GlobeNewswire

2 hours ago

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly

Indeterminate GlobeNewswire

2 hours ago

Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study

Indeterminate GlobeNewswire

2 hours ago

Zscaler Collaborates with IBM and Red Hat to Protect Private Applications from Frontier AI-Powered Threats

Indeterminate GlobeNewswire

2 hours ago

Coveron completes SOC 2 Type II certification with zero exceptions

Indeterminate GlobeNewswire

2 hours ago

Mastercard Selects Rezolve Ai in Worldwide Reseller Agreement to Advance AI-Powered Commerce

Indeterminate GlobeNewswire

2 hours ago

Synoptic Data Secures Lead Subcontractor Role on NOAA’s Five-Year, $1.1B Ceiling National Mesonet Program Contract

Indeterminate GlobeNewswire

2 hours ago

AGM Group Holdings Inc. Announces Closing of US$11.0 million Private Placement

Indeterminate GlobeNewswire

3 hours ago

Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform

Indeterminate GlobeNewswire

3 hours ago

Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors

Indeterminate GlobeNewswire

3 hours ago

BBP-418 Demonstrates Potential to Be Disease Modifying Therapy, Restoring Cardiac and Disease Markers to Unaffected Levels

Indeterminate GlobeNewswire

3 hours ago

FIERCE BIOTECH NAMES REPRONOVO A “FIERCE 15” BIOTECH COMPANY OF 2026

Indeterminate GlobeNewswire